TGFB1 and idiopathic pulmonary fibrosis: In humans, fresolimumab, similar to TGF‐β antibody 1D11 in specificity, has been used for clinical trials in patients with idiopathic pulmonary fibrosis 62, primary focal segmental glomerulosclerosis 63 and cancer 64.